1. Karno M, Golding JM, Sorenson SB, Burnam MA. The epidemiology of obsessive-compulsive disorder in five US communities. Arch Gen Psychiatry 1988;45:1094-1099. PMID:
3264144.
2. Pallanti S, Quercioli L. Treatment-refractory obsessive-compulsive disorder: methodological issues, operational definitions and therapeutic lines. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:400-412. PMID:
16503369.
3. Raveendranathan D, Srinivasaraju R, Ratheesh A, Math SB, Reddy YC. Treatment-refractory OCD responding to maintenance electroconvulsive therapy. J Neuropsychiatry Clin Neurosci 2012;24:E16-E17. PMID:
22772680.
4. Mellman LA, Gorman JM. Successful treatment of obsessive-compulsive disorder with ECT. Am J Psychiatry 1984;141:596-597. PMID:
6703146.
5. Cybulska EM. Obsessive-compulsive disorder, the brain and electroconvulsive therapy. Br J Hosp Med (Lond) 2006;67:77-81. PMID:
16498907.
6. Dell'Osso B, Altamura AC, Allen A, Hollander E. Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions. CNS Spectr 2005;10:966-979. 983PMID:
16344833.
7. Parker G, Roy K, Hadzi-Pavlovic D, Pedic F. Psychotic (delusional) depression: a meta-analysis of physical treatments. J Affect Disord 1992;24:17-24. PMID:
1347545.
8. Alptekin K, Degirmenci B, Kivircik B, Durak H, Yemez B, Derebek E, et al. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive compulsive patients without depression. Psychiatry Res 2001;107:51-56. PMID:
11472864.
9. Swedo SE, Pietrini P, Leonard HL, Schapiro MB, Rettew DC, Goldberger EL, et al. Cerebral glucose metabolism in childhood-onset obsessivecompulsive disorder. Revisualization during pharmacotherapy. Arch Gen Psychiatry 1992;49:690-694. PMID:
1514873.
10. Lacerda AL, Dalgalarrondo P, Caetano D, Camargo EE, Etchebehere EC, Soares JC, et al. Elevated thalamic and prefrontal regional cerebral blood flow in obsessive-compulsive disorder: a SPECT study. Psychiatry Res 2003;123:125-134. PMID:
12850251.
11. Molina V, Montz R, Martin-Loeches M, Jiménez-Vicioso A, Carreras JL, Rubia FJ, et al. Drug therapy and cerebral perfusion in obsessivecompulsive disorder. J Nucl Med 1995;36:2234-2238. PMID:
8523111.
12. Perani D, Colombo C, Bressi S, Bonfanti A, Grassi F, Scarone S, et al. [18F]FDG PET study in obsessive-compulsive disorder. A clinical/metabolic correlation study after treatment. Br J Psychiatry 1995;166:244-250. PMID:
7728370.
13. Saxena S, Brody AL, Schwartz JM, Baxter LR. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. Br J Psychiatry Suppl 1998;26-37. PMID:
9829024.
14. Bremner JD, Vythilingam M, Vermetten E, Nazeer A, Adil J, Khan S, et al. Reduced volume of orbitofrontal cortex in major depression. Biol Psychiatry 2002;51:273-279. PMID:
11958777.
15. Auer DP, Putz B, Kraft E, Lipinski B, Schill J, Holsboer F. Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biol Psychiatry 2000;47:305-313. PMID:
10686265.
16. Pascual-Leone A, Rubio B, Pallardo F, Catala MD. Rapid-rate transcranial magnetic stimulation of left dorsolateral prefrontal cortex in drugresistant depression. Lancet 1996;348:233-237. PMID:
8684201.
17. Perrin JS, Merz S, Bennett DM, Currie J, Steele DJ, Reid IC, et al. Electroconvulsive therapy reduces frontal cortical connectivity in severe depressive disorder. Proc Natl Acad Sci U S A 2012;109:5464-5468. PMID:
22431642.
18. McDonald WM, McCall WV, Epstein CM. Electroconvulsive Therapy: Sixty Years of Progress and a Comparison with Transcranial Magnetic Stimulation and Vagal Nerve Stimulation. In: Kenneth LD, Dennis CJ, Coyle T, Charles N, editor. Neuropsychopharmacology: the Fifth Generation of Progress. Philadelphia, PA: Lippincott Williams & Wilkins, 2002, p. 1097-1108.
19. Frankel FH. The 1978 and 1990 APA Task Force Reports. Convuls Ther 1990;6:79-81. PMID:
11941052.